- Home
- AIRT vs BRNS Comparison
AIRT vs BRNS Comparison
Compare AIRT & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRT | BRNS |
|---|---|---|
| Founded | 1980 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 55.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIRT | BRNS |
|---|---|---|
| Price | $18.75 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 2.1K | ★ 78.4K |
| Earning Date | 02-11-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $279,216,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $14.56 | $0.64 |
| 52 Week High | $26.70 | $2.92 |
Technical Indicators
Market Signals| Indicator | AIRT | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 39.68 | 36.76 |
| Support Level | $19.00 | $0.66 |
| Resistance Level | $20.75 | $0.77 |
| Average True Range (ATR) | 0.45 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 12.90 | 23.06 |
Price Performance
Historical ComparisonAbout AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.